REPLIGEN CORP (RGEN) Operating income 2016–2025
REPLIGEN CORP (RGEN) annual operating income history from SEC filings — each fiscal year as reported.
$55.2MFY2025 · since FY2016: $16.0M → $55.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55.2M | +257.1% |
| FY2024 | -$35.1M | -173.6% |
| FY2023 | $47.7M | -78.8% |
| FY2022 | $224.7M | +34.3% |
| FY2021 | $167.2M | +139.5% |
| FY2020 | $69.8M | +93.5% |
| FY2019 | $36.1M | +38.8% |
| FY2018 | $26.0M | +85.6% |
| FY2017 | $14.0M | -12.3% |
| FY2016 | $16.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGEN financial trends
RGEN RevenueRGEN Net incomeRGEN Net marginRGEN Gross profitRGEN Gross marginRGEN Operating marginRGEN Operating cash flowRGEN Free cash flowRGEN Capital expendituresRGEN Return on equityRGEN Stock buybacksRGEN Dividends paidRGEN Total assetsRGEN Total liabilitiesRGEN Shareholders’ equityRGEN overview →